Case 7 was homozygous for CHEK2 c.1100delC variants and was diagnosed with invasive ductal tumor and abundant ductal carcinoma in situ at the age of 51 years, and had cancer recurrence five years after the initial diagnosis. This evidence concerns the gene CHEK2 and ductal breast carcinoma in situ.